Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form
Patent
1994-10-27
2000-02-22
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
424451, 424464, 424489, 424439, A61K 900, A61K 916, A61K 920, A61K 948
Patent
active
060277378
ABSTRACT:
Novel methods are provided for treating osteoporosis in humans, comprising administering therapeutic amounts of pharmaceutically-acceptable alkalinizing salts of potassium. The preferred salt is potassium bicarbonate. The methods may also be used to prevent or delay the onset of osteoporosis. Dietary supplementation is a preferred and convenient method of administration.
REFERENCES:
patent: 3541208 (1970-11-01), Dann
patent: 3639585 (1972-02-01), Hesse
patent: 3821368 (1974-06-01), Reynolds
patent: 4216237 (1980-08-01), Smith
patent: 4772467 (1988-09-01), Pak
patent: 4814177 (1989-03-01), Walsdorf et al.
patent: 4851221 (1989-07-01), Pak et al.
patent: 4888182 (1989-12-01), Pak
patent: 5171583 (1992-12-01), Morris, Jr. et al.
patent: 5766640 (1998-06-01), Morris, Jr. et al.
A. Goulding et al vol. 133, May 1985 pp. 891-893.
J. Lemann, Jr. et al Abstract A.C.N. Dec. 7-10, 1986.
Ballina et al J. Andocrinol. Invest. 8; 171-173(1985).
Lemann, Jr. et al Kidney Inter. 31(1) 353 1987.
Chem. A b. 2148 F Wolf et al Chem. AB.
New England J. of Med. vol. 330 Jun. 23, 1994 1776-1781.
Lemann, Jr. et al Kidney International 1989 pp. 688-693.
Burnell, Am. J. Physiol. 250:F302-F307 (1986).
Kocian et al., Nutr. Metab. 23:391-398 (1979).
Orsatti et al., Calcif. Tissue Res. 21:195-205 (1976).
Pacifici et al., N. Engl. J. Med. 31:1025 (Oct. 1987).
Richards et al., Lancet 2:994 (1972).
Stacy et al., J. Physiol. 210:549-564 (1970).
Wachman et al., Lancet 2:958-959 (1968).
"Osteoporosis" in Diet and Health Implications for Reducing Chronic Disease Risk, Natl. Res. Council, Ch. 23 (1989).
Dietz, et al., Clin. Sci. 61:69S-71S (1981).
Orsatti, 86 Chem. Abstr. 41549e (1976).
Goldsmith et al., J. Clin. Endo. Metab. 43:523-532 (1976).
Silverberg et al., J. Bone and Mineral Res. 1(4):383-388 (1986).
Lutz, Am. J. Clin. Nutr., 39:281, (Feb. 1984).
Sakhaeee et al., Kidney Int. 24:348 (1983).
Seeman et al., N. Eng. J. Med. 320:554-558 (1989).
Ballina et al., J. Endocrinol Invest. 8:171-174 (1985).
Barzel et al., Clin. Sci. 36:517-524 (1969).
Barzel, In: Barzel, U.S., ed. Osteoporosis: 199-206, (1970).
Barzel, Am. J. Clin. Nutr. 23(6): 833-840 (Jun., 1970).
Barzel, Arch Phys. Med. Rehabil. 52(3): 135-137 (Mar., 1971).
Barzel, Israel Journal of Medical Sciences 7:499 (1972).
Barzel, Calcif. Tissue Res. 21 Suppl: 417-422 (Aug., 1976).
Barzel, Semin. Nucl. Med. 17(4): 283-292 (Oct., 1987).
Morris, Jr. R. Curtis
Sebastian Anthony
Page Thurman K.
The Regents of the University of California
LandOfFree
Treatment for osteoporosis using potassium salts does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment for osteoporosis using potassium salts, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment for osteoporosis using potassium salts will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-518264